Cefpodoxime Oral Suspension IP
*Product image is for representation only. Actual packaging may slightly differ.
Highly effective against both Gram-positive and Gram-negative bacteria.
Formulated as a prodrug for maximum absorption and clinical efficacy.
Palatable suspension base ensuring excellent compliance in young children.
Quickly achieves therapeutic concentrations in respiratory tissues.
Well-tolerated profile suitable for sensitive pediatric patients.
Highly effective treatment for middle ear infections, which are very common in children.
Targets strep throat and associated tonsillar infections rapidly.
A reliable therapeutic option for mild to moderate pediatric pneumonia.
Clears bacterial sinus infections effectively, relieving facial pressure and congestion.
Treats uncomplicated skin and minor skin structure bacterial infections.
*The above information is for general awareness only. Always consult a qualified healthcare professional before use.
Cefpodoxime acts rapidly to disrupt the structural integrity of the bacterial cell wall, leading to fast eradication of the pathogen.
Cefpodoxime penetrates the bacterial cell and binds specifically to essential Penicillin-Binding Proteins (PBPs).
This binding irreversibly inhibits the final transpeptidation step of peptidoglycan synthesis in the cell wall.
The weakened cell wall leads to osmotic instability, bacterial cell lysis, and ultimately, cell death.
*This information is for general awareness only and does not constitute medical advice. Always consult your doctor.
Pediatric DoseChildren (2 months to 12 years): 10 mg/kg/day administered in two divided doses every 12 hours.
⚠️ Consult pediatrician if side effects persist or become severe.
*The clinical information above is for general awareness only. Always consult a qualified physician before starting or changing any medication.
Contact our team for pricing, availability, and distribution partnerships across India.